- XLO +3.71%
Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth?
Yahoo Finance · 1 week ago
Open | 0.8600 |
High | 0.8999 |
Low | 0.8600 |
Mkt Cap | 33.04M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 0.8630 |
52 Wk. Low | 0.4900 |
52 Wk. High | 2.9400 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -17.2M | - |
Diluted EPS | -0.62 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.23 | - |
Q1 2024 | -$0.11 | -$0.62 |
Q4 2023 | -$0.64 | -$0.64 |
S&P 500^GSPC | 5,567.19+30.17 (+0.54%) |
Dow 30^DJI | 39,375.87+67.87 (+0.17%) |
Nasdaq^IXIC | 18,352.76+164.46 (+0.90%) |
Bitcoin USDBTC-USD | 58,024.99+2.97% |
XRP USDXRP-USD | 0.45+4.16% |
210.33+0.06% |